BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 30012566)

  • 1. The Splicing Factor PTBP1 Promotes Expression of Oncogenic Splice Variants and Predicts Poor Prognosis in Patients with Non-muscle-Invasive Bladder Cancer.
    Bielli P; Panzeri V; Lattanzio R; Mutascio S; Pieraccioli M; Volpe E; Pagliarulo V; Piantelli M; Giannantoni A; Di Stasi SM; Sette C
    Clin Cancer Res; 2018 Nov; 24(21):5422-5432. PubMed ID: 30012566
    [No Abstract]   [Full Text] [Related]  

  • 2. Polypyrimidine tract binding protein 1 promotes lymphatic metastasis and proliferation of bladder cancer via alternative splicing of MEIS2 and PKM.
    Xie R; Chen X; Chen Z; Huang M; Dong W; Gu P; Zhang J; Zhou Q; Dong W; Han J; Wang X; Li H; Huang J; Lin T
    Cancer Lett; 2019 May; 449():31-44. PubMed ID: 30742945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of PTBP1 promote invasion of colorectal cancer by alternative splicing of cortactin.
    Wang ZN; Liu D; Yin B; Ju WY; Qiu HZ; Xiao Y; Chen YJ; Peng XZ; Lu CM
    Oncotarget; 2017 May; 8(22):36185-36202. PubMed ID: 28404950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significance of Polypyrimidine Tract-Binding Protein 1 Expression in Colorectal Cancer.
    Takahashi H; Nishimura J; Kagawa Y; Kano Y; Takahashi Y; Wu X; Hiraki M; Hamabe A; Konno M; Haraguchi N; Takemasa I; Mizushima T; Ishii M; Mimori K; Ishii H; Doki Y; Mori M; Yamamoto H
    Mol Cancer Ther; 2015 Jul; 14(7):1705-16. PubMed ID: 25904505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Combination RNAi toward Warburg Effect by Replacement with miR-145 and Silencing of PTBP1 Induces Apoptotic Cell Death in Bladder Cancer Cells.
    Takai T; Yoshikawa Y; Inamoto T; Minami K; Taniguchi K; Sugito N; Kuranaga Y; Shinohara H; Kumazaki M; Tsujino T; Takahara K; Ito Y; Akao Y; Azuma H
    Int J Mol Sci; 2017 Jan; 18(1):. PubMed ID: 28106737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long noncoding RNA HCG22 suppresses proliferation and metastasis of bladder cancer cells by regulation of PTBP1.
    Jiang D; Zhang Y; Yang L; Lu W; Mai L; Guo H; Liu X
    J Cell Physiol; 2020 Feb; 235(2):1711-1722. PubMed ID: 31304601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Skipping of exon 10 in
    Shen L; Lei S; Zhang B; Li S; Huang L; Czachor A; Breitzig M; Gao Y; Huang M; Mo X; Zheng Q; Sun H; Wang F
    Theranostics; 2020; 10(13):5719-5735. PubMed ID: 32483414
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypyrimidine tract-binding protein 1-mediated down-regulation of ATG10 facilitates metastasis of colorectal cancer cells.
    Jo YK; Roh SA; Lee H; Park NY; Choi ES; Oh JH; Park SJ; Shin JH; Suh YA; Lee EK; Cho DH; Kim JC
    Cancer Lett; 2017 Jan; 385():21-27. PubMed ID: 27836735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTBP1 enhances exon11a skipping in Mena pre-mRNA to promote migration and invasion in lung carcinoma cells.
    Li S; Shen L; Huang L; Lei S; Cai X; Breitzig M; Zhang B; Yang A; Ji W; Huang M; Zheng Q; Sun H; Wang F
    Biochim Biophys Acta Gene Regul Mech; 2019 Aug; 1862(8):858-869. PubMed ID: 31075540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal PTBP1 Expression Sustains the Disease Progression of Multiple Myeloma.
    Bai H; Chen B
    Dis Markers; 2020; 2020():4013658. PubMed ID: 32655719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia induced LUCAT1/PTBP1 axis modulates cancer cell viability and chemotherapy response.
    Huan L; Guo T; Wu Y; Xu L; Huang S; Xu Y; Liang L; He X
    Mol Cancer; 2020 Jan; 19(1):11. PubMed ID: 31964396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation and functional significance of CDC42 alternative splicing in ovarian cancer.
    He X; Yuan C; Yang J
    Oncotarget; 2015 Oct; 6(30):29651-63. PubMed ID: 26336992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MYCN controls an alternative RNA splicing program in high-risk metastatic neuroblastoma.
    Zhang S; Wei JS; Li SQ; Badgett TC; Song YK; Agarwal S; Coarfa C; Tolman C; Hurd L; Liao H; He J; Wen X; Liu Z; Thiele CJ; Westermann F; Asgharzadeh S; Seeger RC; Maris JM; Guidry Auvil JM; Smith MA; Kolaczyk ED; Shohet J; Khan J
    Cancer Lett; 2016 Feb; 371(2):214-24. PubMed ID: 26683771
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    Huang SP; Chen LC; Chen YT; Lee CH; Huang CY; Yu CC; Lin VC; Lu TL; Bao BY
    Cancer Genomics Proteomics; 2021; 18(3):325-334. PubMed ID: 33893085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PTBP1-dependent regulation of USP5 alternative RNA splicing plays a role in glioblastoma tumorigenesis.
    Izaguirre DI; Zhu W; Hai T; Cheung HC; Krahe R; Cote GJ
    Mol Carcinog; 2012 Nov; 51(11):895-906. PubMed ID: 21976412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of BCL-X splicing reveals a role for the polypyrimidine tract binding protein (PTBP1/hnRNP I) in alternative 5' splice site selection.
    Bielli P; Bordi M; Di Biasio V; Sette C
    Nucleic Acids Res; 2014 Oct; 42(19):12070-81. PubMed ID: 25294838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PTBP1 promotes the progression of hepatocellular carcinoma by enhancing the oncogenic splicing switch of FGFR2.
    Yu-Ying C; Qian Z; Meng-Hui G; Lan F; Peng-Bo C; Gang-Qiao Z
    Yi Chuan; 2024 Jan; 46(1):46-62. PubMed ID: 38230456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SON drives oncogenic RNA splicing in glioblastoma by regulating PTBP1/PTBP2 switching and RBFOX2 activity.
    Kim JH; Jeong K; Li J; Murphy JM; Vukadin L; Stone JK; Richard A; Tran J; Gillespie GY; Flemington EK; Sobol RW; Lim SS; Ahn EE
    Nat Commun; 2021 Sep; 12(1):5551. PubMed ID: 34548489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative microexon splicing by RBFOX2 and PTBP1 is associated with metastasis in colorectal cancer.
    Mochizuki Y; Funayama R; Shirota M; Kikukawa Y; Ohira M; Karasawa H; Kobayashi M; Ohnuma S; Unno M; Nakayama K
    Int J Cancer; 2021 Nov; 149(10):1787-1800. PubMed ID: 34346508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Implication of Urothelial Stem Cell Markers Differs According to Primary Tumour Location in Non-Muscle-Invasive Bladder Cancer.
    Wang L; Zhao J; Yang C; Kuang R; Kazobinka G; Pang Z; Hou T
    Cell Physiol Biochem; 2018; 48(6):2364-2373. PubMed ID: 30114689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.